Hematological changes observed in female beagle given ethynylestradiol.
D000284:Administration, Oral; D000818:Animals; D001773:Blood Cells / Q000187:drug effects*; D001780:Blood Coagulation Tests; D001792:Blood Platelets / Q000187:drug effects; D001799:Blood Sedimentation; D001853:Bone Marrow / Q000187:drug effects*; D001854:Bone Marrow Cells; D004285:Dogs; D004906:Erythrocyte Count; D004912:Erythrocytes / Q000187:drug effects; D004971:Estrus / Q000187:drug effects; D004997:Ethinyl Estradiol / Q000494:pharmacology / Q000633:toxicity*; D005260:Female; D006400:Hematocrit; D006474:Hemorrhagic Disorders / Q000139:chemically induced; D006965:Hyperplasia / Q000139:chemically induced; D007958:Leukocyte Count; D007962:Leukocytes / Q000187:drug effects; D007964:Leukocytosis / Q000139:chemically induced; D011247:Pregnancy; D011517:Prothrombin Time; D013921:Thrombocytopenia / Q000139:chemically induced; D013997:Time Factors
D004997:Ethinyl Estradiol